Literature DB >> 18217883

Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

N Klepac1, V Trkulja, M Relja, T Babić.   

Abstract

Whilst the association between dementia and poorer health-related quality of life (Hr-QoL) in Parkinson's disease (PD) has been well established, we aimed to explore the relationship between cognitive performance and Hr-QoL in PD without dementia. Consecutive PD patients (n = 124, 54% men, age 60.4 +/- 10.3 years) judged as non-demented based on DSM-IV criteria and Mini Mental State Examination, free of other neurodegenerative diseases or psychotic difficulties and antipsychotic/antidepressive/anxyolitic treatment were assessed in a battery of neuropsychological tests. We used Parkinson's disease questionnaire (PDQ-39) to asses Hr-QoL and Beck's Depression Inventory (BDI) to quantify depression. In the univariate analysis, better performance in each of the tests evaluating visual attention/memory or visuospatial and executive functions was associated with better Hr-QoL. In multivariate analysis [adjustment for BDI score, PD severity and duration, l-dopa dose, age, sex, education, employment status and early PD onset (<50 years of age)] in which these tests were either represented by a common variable identified in a principal components analysis or were considered individually, better cognitive performance was independently associated with better Hr-QoL. The association was conditional on the level of depression, i.e., apparent only in patients with low(er) BDI scores. Cognitive performance appears associated with Hr-QoL even in non-demented PD patients.

Entities:  

Mesh:

Year:  2008        PMID: 18217883     DOI: 10.1111/j.1468-1331.2007.02011.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  48 in total

1.  GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Debby Tsuang; Haley Huston; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

2.  Feasibility of a cognitive strategy training intervention for people with Parkinson's disease.

Authors:  Erin R Foster; Daniel Spence; Joan Toglia
Journal:  Disabil Rehabil       Date:  2017-02-23       Impact factor: 3.033

3.  A differential deficit in time- versus event-based prospective memory in Parkinson's disease.

Authors:  Sarah A Raskin; Steven Paul Woods; Amelia J Poquette; April B McTaggart; Jim Sethna; Rebecca C Williams; Alexander I Tröster
Journal:  Neuropsychology       Date:  2011-03       Impact factor: 3.295

Review 4.  [Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers].

Authors:  B Mollenhauer; F Sixel-Döring; A Storch; C Schneider; R Hilker; E Kalbe
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

5.  Relation of Parkinson's disease subtypes to visual activities of daily living.

Authors:  Daniel R Seichepine; Sandy Neargarder; Ivy N Miller; Tatiana M Riedel; Grover C Gilmore; Alice Cronin-Golomb
Journal:  J Int Neuropsychol Soc       Date:  2011-08-04       Impact factor: 2.892

Review 6.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

7.  Prospective memory in Parkinson disease during a virtual week: effects of both prospective and retrospective demands.

Authors:  Erin R Foster; Nathan S Rose; Mark A McDaniel; Peter G Rendell
Journal:  Neuropsychology       Date:  2013-03       Impact factor: 3.295

8.  The cognition and emotional well-being indices of the Parkinson's disease questionnaire-39: what do they really measure?

Authors:  Jacob D Jones; Chris Hass; Paul Mangal; Jacob Lafo; Michael S Okun; Dawn Bowers
Journal:  Parkinsonism Relat Disord       Date:  2014-09-18       Impact factor: 4.891

9.  Side and type of initial motor symptom influences visuospatial functioning in Parkinson's disease.

Authors:  Daniel R Seichepine; Sandy Neargarder; Sigurros Davidsdottir; Gretchen O Reynolds; Alice Cronin-Golomb
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

10.  Mood and energy determinants of quality of life in dystonia.

Authors:  Anne Soeder; Benzi M Kluger; Michael S Okun; Cynthia W Garvan; Thomas Soeder; Charles E Jacobson; Ramon L Rodriguez; Rick Turner; Hubert H Fernandez
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.